drugset / Trial / NCT05985278
Clinical Application of Lutetium [177Lu]-Catalase in Tumor Radionuclide Therapy
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the retention in tumour and distribution behavior of \[Lu-177\]-Catalase after intratumoral injection,and preliminary evaluation the efficacy and safety of \[Lu-177\]-Catalase.
Timeline
- Start
- 2023-07-06
- Primary completion
- 2026-06-15
- Completion
- 2026-06-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | [ Lu-177]-Catalase | Unknown | — | Other |